ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 599

Association Between Serum Leptin and Adiponectin Levels With The Severity Of Proteinuria In Lupus Nephritis

Valeria Diaz-Rizo1, Nicte Selene Fajardo-Robledo2, Alan Joel Ruiz-Padilla2, Dalia Sanchez-Mosco3, Tania Marlene Rodriguez-Hernandez4, Xochitl Trujillo5, Miguel Huerta5, Monica Vazquez del Mercado6, Laura Gonzalez-Lopez4 and Jorge Ivan Gamez-Nava7, 1Doctorado en Ciencias Médicas, Centro Universitario de Investigación Biomédica, Universidad de Colima; UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico, 2Fisiología, Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, 3Centro Universitario de Investigación Biomédica, Universidad de Colima; Hospital General Regional 110 IMSS, Guadalajara, Jalisco, Mexico, 4Departamento de Medicina Interna/Rheumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico, 5Centro Universitario de Investigación Biomédica, Universidad de Colima, Colima, Mexico, 6Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, 7UMAE, Centro Médico Nacional de Occidente, IMSS; Doctorado en Farmacología, Universidad de Guadalajara, Jalisco, Mexico

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Adipocytokines, lupus nephritis and proteinuria

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects I - Renal, Malignancy, Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: To identify the association between serum leptin and adiponectin levels and proteinuria secondary to lupus nephritis in women with systemic lupus erythematosus (SLE). 

Methods: One-hundred and four women with SLE were included in the study. All of them were assessed in order to identify the presence of lupus nephritis; proteinuria levels in 24 hours were identified, patients were classified in two groups: SLE with proteinuria ≥0.5 g in 24 h secondary to lupus nephritis (SLE + proteinuria n=30) and SLE without nephritis (n=74). Patients with proteinuria secondary to causes different to nephritis were excluded. Other assessments included modified-SLEDAI (m-SLEDAI) for disease activity, SLICC/ACR and Body Mass Index (BMI). Serum levels of leptin, and adiponectin were measured by ELISA. Leptin was adjusted by BMI. Statistical analysis included a comparison of means between groups using Student t-test for independent samples, Pearson correlation test to identify strength of association between serum leptin and adiponectin levels with proteinuria and other quantitative variables. A multiple regression analysis was used to adjust for confounders.

Results: In the comparison between groups there were no statistically significant differences in age, weight or BMI between SLE + proteinuria versus SLE without nephritis. The group with SLE + proteinuria had higher serum adiponectin levels compared with SLE without nephritis (20.11±10.58 μg/mL vs. 15.36±7.83 μg/mL respectively; p=0.032). Serum leptin levels were not statistically different between the group with SLE + proteinuria compared with SLE without nephritis (28.68±25.79 ng/mL vs. 23.43±29.15 ng/mL respectively; p=0.39). Serum leptin levels had a positive correlation with weigh (r=0.306, p=0.002), BMI (r=0.327, p=0.001), serum creatinine in mg/dL (r=0.283, p=0.004), chloroquine (r=0.262, p=0.009) and prednisone doses (mg/day) (r=0.207, p=0.035) but did not correlated with proteinuria (r=-0.014, p=0.893) neither with m-SLEDAI (r=0.092, p=0.357) and SLICC/ACR (r=0.083, p=0.408). Serum adiponectin levels correlated with serum creatinine (r=0.255, p=0.010) and proteinuria (r=0.305, p=0.002), m-SLEDAI (r=0.299, p=0.002), chloroquine (r=0.203, p=0.046) and prednisone doses (r=0.343, p=<0.001), but there was no correlation between adiponectin and SLICC/ACR (r=0.085, p=0.394). A negative correlation was observed between adiponectin and weigh (r=-0.204, p=0.038), BMI (r=-0.203, p=0.039) and fast glucose serum levels (r=-0.347, p=<0.001). In the multivariate analysis, after adjusting by age, disease duration, BMI and leptin, serum adiponectin levels remained associated with severity of proteinuria (p=0.005).

Conclusion: Serum adiponectin levels were higher in women with SLE + proteinuria compared to SLE without nephritis. Longitudinal studies should be performed in order to identify if patients with proteinuria and high serum adiponectin levels have differences in the development of response to therapies directed against of nephritis.

Founding: This project was supported by Instituto Mexicano del Seguro Social with the no. FIS/IMSS/PROT/G11/937.


Disclosure:

V. Diaz-Rizo,
None;

N. S. Fajardo-Robledo,
None;

A. J. Ruiz-Padilla,
None;

D. Sanchez-Mosco,
None;

T. M. Rodriguez-Hernandez,
None;

X. Trujillo,
None;

M. Huerta,
None;

M. Vazquez del Mercado,
None;

L. Gonzalez-Lopez,
None;

J. I. Gamez-Nava,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-serum-leptin-and-adiponectin-levels-with-the-severity-of-proteinuria-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology